Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,103 recruiting studies in this area right now.
By phase
- Not applicable4,204
- Phase 2591
- Phase 1413
- Phase 3328
- Phase 4255
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer226
- Endometrial Cancer210
- Bladder Cancer187
- Acute Kidney Injury135
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer111
- Chronic Kidney Disease108
- Infertility91
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension59
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama154
- Texas118
- Massachusetts117
- New York117
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,103 total
- NCT02297724Recruiting
MRI checks placental health in twin or single growth restriction
This trial uses an MRI scan to look at placental health in pregnancies where the baby (or one twin) is not growing as expected. The goal is to better understand placental problems and how they may affect baby growth.
Boston, MassachusettsAges 18–45 - NCT05519241RecruitingPhase 1
Experimental bladder cancer treatment for early-stage, BCG-unresponsive disease
This phase 1 trial tests a new treatment for early-stage bladder cancer that has not responded to BCG therapy. The treatment is given directly into the bladder (intravesical), which may help avoid removing the bladder.
Boston, MassachusettsAges 18 years+ - NCT05513417Enrolling by invitation
Digital pelvic health program for women with pelvic pain
This study tests a digital (phone/app-based) program to help women with pelvic pain or pelvic health symptoms. It may help by guiding pelvic-focused exercises and care, especially if you’re recovering from pelvic surgery or managing ongoing symptoms.
Draper, UtahAges 18–99 - NCT05536141RecruitingPhase 1
Study of AB521 for kidney cancer and other solid tumors
This early-stage trial tests AB521, alone and in combination with other medicines, in people with advanced solid tumors—especially clear cell kidney cancer. It aims to find a safe dose and see whether the treatment could help shrink tumors or control the disease.
Birmingham, AlabamaAges 18 years+ - NCT05548296RecruitingPhase 2
ACR-368 for high-grade endometrial cancer after prior treatments
This Phase 2 trial studies ACR-368 for people with high-grade endometrial cancer that has spread or grown despite at least one prior treatment. It may help by testing whether this drug can better control the cancer after other therapies have not worked.
Mobile, AlabamaAges 18 years+ - NCT04982419RecruitingPhase 2/Phase 3
Remote arm treatment to protect heart and kidneys in heart failure
This trial tests whether a simple “arm cuff” treatment done before a heart artery procedure can help protect the kidneys and the heart in people with congestive heart failure. If it works, it may lower the chance of kidney injury around the time of the scan/stent procedure.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT05538338Recruiting
Platelet-rich plasma to improve thin uterine lining
This trial studies whether platelet-rich plasma (PRP) can help grow a thin uterine lining enough to support a pregnancy. It is aimed at people who have had repeated unsuccessful frozen embryo transfers and had a lining of 6 mm or less.
Basking Ridge, New JerseyAges 18–45 - NCT05523284Enrolling by invitation
Ultrasound and blood tests to diagnose superficial endometriosis
This study tests whether a combination of ultrasound and blood samples (biomarkers) can help diagnose superficial endometriosis. It may help people who have symptoms but aren’t sure what’s causing them get clearer results.
Hamilton, OntarioAges 18 years+ - NCT05505500Recruiting
Parent and patient interviews for childhood kidney swelling
This study uses interviews to understand how swelling from nephrotic syndrome affects daily life for children and their caregivers. It may help researchers design better care by capturing the patient and parent perspective.
Ann Arbor, MichiganAges 2 years+ - NCT05542407RecruitingPhase 1
ONC201 plus atezolizumab for endometrial cancer and obesity
This Phase 1 study tests ONC201 together with atezolizumab in people with metastatic or returning endometrial cancer, especially when obesity may be driving the cancer. It aims to find a safe dose and see whether the combination can slow the cancer’s growth.
Chapel Hill, North CarolinaAges 18 years+ - NCT05528796Enrolling by invitation
Finding causes of non-immune fluid buildup in babies
This study looks for the underlying cause of “non-immune hydrops fetalis,” a serious condition where a baby has abnormal fluid buildup. It focuses on families whose usual genetic tests didn’t find an answer (or weren’t completed before birth).
San Francisco, CaliforniaAges 18–60 - NCT05528237Enrolling by invitation
HPV self-test to help cervical cancer screening access
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
Seattle, WashingtonAges 25 years+ - NCT05524480Enrolling by invitation
Help Latina women get overdue breast, cervical care
This trial tests an implementation program that helps clinics better provide breast and cervical cancer screening and HPV vaccination to Latina women who are behind on recommended care. It may help you catch up on screening or start HPV vaccination and connect you to low-cost services.
Houston, TexasAges 18–74 - NCT05521776Recruiting
Early pregnancy screening to reduce complications after high blood pressure
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
AngersAges 18 years+ - NCT05537454Recruiting
Stress and breast milk in preterm baby development
This study looks at how a mother's stress may affect her breast milk and the development of her preterm baby. Participation involves providing breast milk samples and answering questions about stress, which could help understand how to support preterm infant growth and brain development.
Minneapolis, MinnesotaAges 6 months–8 months - NCT05538208RecruitingPhase 2
Children with lupus kidney inflammation using mycophenolate
This Phase 2 study tests how well the medicine mycophenolate mofetil (MMF) works for children and teens with lupus nephritis that is “proliferative” (a specific biopsy type). You may qualify if your kidney biopsy and current treatment match the study’s targets and you can follow frequent visits and testing.
San Francisco, CaliforniaAges 8–20 - NCT05533645Recruiting
Questionnaire study about salt (sodium) intake
This study asks people to report how much salt they eat so researchers can better understand sodium intake in people with high blood pressure and/or advanced kidney disease. It may help improve how salt-related health risks are assessed, though it mainly involves questionnaires and scheduled participation.
LilleAges 18 years+ - NCT05544084Recruiting
Patient navigation program for cervical screening in Senegal
This study tests a patient “navigator” approach to improve cervical cancer screening and prevention access in Senegal. You may be invited to help through community education, health facility work, or by being part of a screening-support household.
DakarAges 25–69 - NCT05538091RecruitingPhase 2
Testing vismodegib plus atezolizumab for platinum-resistant ovarian cancer
This Phase 2 trial tests whether combining vismodegib with atezolizumab can slow or shrink platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. It targets cancers that grow again within 6 months after platinum chemotherapy.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT05465044Recruiting
Twice-weekly dialysis for veterans starting kidney treatment
This study compares starting hemodialysis two times per week versus three times per week for veterans in their first year of dialysis. It aims to see if a less frequent schedule can be just as safe and effective for those who still make urine.
Long Beach, CaliforniaAges 18 years+ - NCT00389142Recruiting
Find genes linked to bladder pain and urinary symptoms
This study looks for genetic (inherited) causes of bladder pain syndrome (IC/BPS), using information from people who have typical urinary symptoms. It may help doctors understand why IC/BPS happens, which could guide better future care.
Boston, MassachusettsAges 1 year+ - NCT05489211RecruitingPhase 2
Testing a cancer drug for advanced solid tumors
This Phase 2 study tests the drug Dato-DXd (alone or with other cancer medicines) in people with advanced solid tumors. It looks for tumor shrinkage and how safely the treatment can be given.
Los Angeles, CaliforniaAges 18–130 - NCT05503797RecruitingPhase 2
Study of FORE8394 for cancers with BRAF changes
This trial tests a new drug, FORE8394, for people whose cancers have a change in the BRAF gene. It may be an option if you have a solid tumor or brain tumor that has not responded to other treatments.
Beverly Hills, CaliforniaAges 8 years+ - NCT05485961RecruitingPhase 2/Phase 3
Clazakizumab for kidney failure patients on dialysis
This study tests an experimental drug called clazakizumab (CSL300) to see if it can reduce inflammation and lower the risk of heart problems in people with kidney failure who are on dialysis. It may help if you have diabetes or heart disease and have high inflammation levels.
Decatur, AlabamaAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,103 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,012 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.